Table 2.
Major clinical features of the cell lines used in this study
| Cell lines | Status | Single-helical scan | Double-helical scan | ||
|---|---|---|---|---|---|
| DSB recognition | DSB repair | DSB recognition | DSB repair | ||
| Fibroblasts | |||||
| 200CLB | Apparently healthy | + | + | + | + |
| RACKHAM01 | Neurofibromatosis type 1+/− | − | − | − | − |
| RACKHAM12 | Neurofibromatosis type 1+/− | − | + | + | + |
| RACKHAM39 | Neurofibromatosis type 1+/− | − | − | − | + |
| 01HNG | Cancer patient | − | − | + | + |
| 02HNA | Cancer patient | − | + | − | + |
| 13HNG | Cancer patient | − | − | + | − |
| GM03399 | Ataxia-telangiectasia mutated+/− | − | − | − | − |
| 85MA | p53+/− | − | − | + | − |
| Astrocytes | |||||
| HA | Apparently healthy | − | − | − | − |
| HA-sp | Apparently healthy | − | + | − | − |
| HA-h | Apparently healthy | + | + | − | + |
| HA-bs | Apparently healthy | − | − | − | + |